Biotarget is a company established in 2016 as a combination of scientific competences in the field of molecular biology, immunochemistry, but also business and commercialization competences.

Biotarget conducts R&D in the areas of immunomodulation, immunostimulation, medicinal products in the form of FSMPs, putting particular emphasis on cancer and infectious diseases.

Information about inquiries for the project

Scroll to top